Kanda, Hironori
Yamawaki, Kengo
Funding for this research was provided by:
Kyowa Kirin Co.,Ltd.
Article History
Received: 11 August 2019
Accepted: 11 June 2020
First Online: 27 June 2020
Compliance with ethical standards
:
: The authors are employees of Kyowa Kirin Co., Ltd., which has the exclusive rights to develop and commercialize bardoxolone methyl in kidney disease and other indications in Japan, China, Taiwan, South Korea, and Southeast Asia.
: This article does not contain any studies with human participants or animals performed by any of the authors.